Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species
Abstract Reactive oxygen species (ROS) is promising in cancer therapy by accelerating tumor cell death, whose therapeutic efficacy, however, is greatly limited by the hypoxia in the tumor microenvironment (TME) and the antioxidant defense. Amplification of oxidative stress has been successfully empl...
Saved in:
| Main Authors: | Jinglin Zou, Cong Jiang, Qiangsheng Hu, Xinlin Jia, Shuqi Wang, Shiyue Wan, Yuanqing Mao, Dapeng Zhang, Peng Zhang, Bin Dai, Yongsheng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-55658-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
by: Hussein Sabit, et al.
Published: (2025-06-01) -
Targeting tumor angiogenesis and metabolism with photodynamic nanomedicine
by: Yong Lv, et al.
Published: (2025-04-01) -
Progress in nanomedicine for sonodynamic immunotherapy of tumors
by: Ziyan Feng, et al.
Published: (2024-09-01) -
Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
by: Liudmyla Maksymova, et al.
Published: (2025-03-01) -
Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy
by: Jiaxin Li, et al.
Published: (2025-10-01)